Sectoral Asset Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Sectoral Asset Management’s Portfolio GEVA Stock Details GEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-365,684	Closed	-$35.7M	–	96
2015 Q1	$35.7M	Buy	365,684 +1,800	+0.5%	+$191K	1.35%	26
2014 Q4	$33.8M	Sell	363,884 -238,461	-40%	-$18.8M	1.51%	27
2014 Q3	$41.4M	Buy	602,345 +85,900	+17%	+$6.15M	1.74%	20
2014 Q2	$54.1M	Buy	516,445 +51,300	+11%	+$4.36M	2.29%	15
2014 Q1	$38.6M	Sell	465,145 -273,860	-37%	-$25.3M	1.59%	24
2013 Q4	$47.8M	Buy	739,005 +268,055	+57%	+$15.9M	2.06%	24
2013 Q3	$29.9M	Buy	+470,950	New	+$23.2M	1.44%	23

Sectoral Asset Management's GEVA Position: Q2 2015 in Review

Sectoral Asset Management sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 365,684 shares — an estimated $35.7M sold.

Sectoral Asset Management first reported a position in GEVA in Q3 2013 and held it in 7 quarters. The position peaked at $54.1M in Q2 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

Sectoral Asset Management reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Sectoral Asset Management sold 365,684 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $35.7M.
Sectoral Asset Management first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q3 2013 and held it in 7 quarters.
Sectoral Asset Management's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $54.1M in Q2 2014.
0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Sectoral Asset Management's 13F filing for Q2 2015, filed 13 Aug 2015.